Silphium Asset Management LTD Arrowhead Pharmaceuticals, Inc. Transaction History

Silphium Asset Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2025	SELL	$10.74 - $19.7 $247,148 - $453,336	-23,012 Closed	0 $0
Q2 2018 Jan 30, 2025	SELL	$6.37 - $14.02 $191,100 - $420,600	-30,000 Reduced 56.59%	23,012 $313 Million
Q1 2018 Jan 30, 2025	BUY	$3.72 - $7.64 $197,204 - $405,011	53,012 New	53,012 $382 Million

293

90.2M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.14B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Silphium Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Silphium Asset Management LTD with notifications on news.